| Literature DB >> 32792769 |
Venkataram Mysore1, A Somaiah Savitha2, Aniketh Venkataram1, Arun C Inamadar3, Aurangabadkar Sanjeev4, S Byalekere Chandrashekar5, Dinesh K Devaraj6, Niti Khunger7, Raghunatha R Reddy2, Pangti Rashi8, Thurakkal Salim9, Sharad D Mutalik10, Shehnaz Arsiwala11,12,13, Shyamanta Barua14, Somesh Gupta8, Subodh Sirur15, Swapnil Shah16.
Abstract
BACKGROUND: Amid the coronavirus disease 2019 (COVID-19) pandemic, dermatologists must be prepared to restructure their practice of procedural dermatology and cutaneous aesthetic surgeries. The COVID-19 pandemic has presented several challenges and has ushered in several changes in practice such as teledermatology, with many physicians adopting virtual consultations and treatments. Performing procedures in the times of COVID-19 pandemic presents challenges such as risk of transmission to doctors and staff due to potential aerosolization, release of virus droplets during the procedures, and risk of virus transfer through the instruments both in the peri- and postoperative period. This can have several medical, administrative, and legal implications.Entities:
Keywords: Aesthetic dermatology; coronavirus disease 2019; dermatosurgery
Year: 2020 PMID: 32792769 PMCID: PMC7394118 DOI: 10.4103/JCAS.JCAS_83_20
Source DB: PubMed Journal: J Cutan Aesthet Surg ISSN: 0974-2077
Persistence of coronaviruses on different types of inanimate surfaces[9]
| Type of surface | Virus | Temperature | Persistence |
|---|---|---|---|
| Steel | HCoV | 21°C | 5 days |
| Aluminum | HCoV | 21°C | 2–8 h |
| Metal | SARS-CoV | RT | 5 days |
| Wood | SARS-CoV | RT | 4 days |
| Paper | SARS-CoV Strain P9 | RT | 4–5 days |
| SARS-CoV Strain GVU6109 | RT | 24h (106 inoculum) | |
| 3h (105 inoculum) | |||
| <5 min (104 inoculum) | |||
| Glass | SARS-CoV | RT | 4 days |
| HCoV | 21°C | 5 days | |
| Plastic | SARS-CoV Strain HKU39849 | 22°–25°C | ≤5 days |
| SARS-CoV Strain P9 | RT | 4 days | |
| SARS-CoV Strain FFM1 | RT | 6–9 days | |
| HCoV Strain 229E | RT | 2–6 days | |
| PVC | HCoV | 21°C | 5 days |
| Silicon rubber | HCoV | 21°C | 5 days |
| Surgical glove (latex) | HCoV | 21°C | ≤ 8 h |
| Disposable gown | SARS-CoV | RT | 2 days (106 inoculum) |
| 24h (105 inoculum) | |||
| 1h (104 inoculum) | |||
| Ceramic | HCoV | 21°C | 5 days |
| Teflon | HCoV | 21°C | 5 days |
HCoV = human coronavirus, SARS = severe acute respiratory syndrome, RT = room temperature
Figure 1Hand sanitizing method with sanitizer. (Image adopted from https://www.who.int/gpsc/5may/hh-relay-procedure.pdf?ua=1)
Figure 2How to wear and remove N95 masks
Figure 3Donning of PPE. (Adapted from www.gov.uk/government/publications/covid-19-personal-protective-equipment-use-for-aerosol-generating-procedures.)
Figure 4Doffing of PPE. (Adapted from www.gov.uk/government/publications/covid-19-personal-protective-equipment-use-for-aerosol-generating-procedures)
Recommended PPE during COVID-19 outbreak—according to the setting, personnel, and type of activity
| Setting | Target personnel or patients | Activity | Risk | Type of PPE or procedure | Remarks |
|---|---|---|---|---|---|
| Point of entry | Reception | Provide information/registration | Low | If there is a physical barrier—no PPE | Ideally, build transparent partition to create a barrier (no PPE required) or minimum distance of 1 m needs to be maintained. |
| If there is no physical barrier—Triple-layer medical mask | |||||
| Temperature recording station | Record temperature with handheld thermal recorder | Low | Triple-layer medical mask gloves | ||
| Healthcare facility—Outpatient. All hospitals should identify a separate triage and holding area for patients with influenza-like illness. If there is no triage area/holding area for patients due to resource constraints, such hospitals will follow the above guidance for general OPD. | Screening | Preliminary screening not involving direct contact | Moderate | N95 mask, gloves, provide triple-layer mask to patient | To maintain physical distance of at least 1 m. Patient to be masked |
| Waiting area | Nurses/paramedic interacting with patients | Moderate | N95 mask gloves | Minimum distance of 1 m needs to be maintained | |
| Doctor’s chamber | Clinical management (doctors, nurses) | Moderate | N95 mask, gloves | No aerosol-generating procedures should be allowed | |
| Waiting area | Visitors accompanying young children and elderly | Low | Triple-layer medical mask | No other visitors should be allowed to accompany patients in OPD settings. Those allowed should practice hand hygiene | |
| Patients with influenza-like illness | Any care activity | Moderate | N95 mask, gloves, eye protection | Maintain physical distance of at least 1 m. Provide medical mask to the patient. Immediately move the patient to a separate room away from others. Perform hand hygiene and have the patient perform hand hygiene | |
| Patients with no symptoms suggestive of COVID-19 | Any care activity | Low | Triple-layer surgical mask | Perform hand hygiene and have the patient perform hand hygiene | |
| Patient room/ward | HCWs | Not providing direct care to COVID-19 patients, or not attending aerosol-generating procedure | Moderate | Medical mask, gown, gloves, eye protection (goggles or face shield) | Perform hand hygiene |
| HCWs | Providing direct care to COVID-19 patients, or attending aerosol-generating procedure | High | N95 mask or equivalent, gown, gloves, eye protection, apron | Perform hand hygiene | |
| Sanitary staff | Cleaning frequently touched surfaces/floor/cleaning linen | Moderate | N95 mask, gloves | ||
| Cleaners | Entering the room of COVID-19 patients | Moderate | Medical mask, gown, heavy-duty gloves, eye protection (if risk of splash from organic material or chemicals is anticipated), closed work shoes | Perform hand hygiene | |
| Visitors | Entering the room of a COVID-19 patient | Moderate | Medical mask, gown, gloves | Maintain physical distance of at least 1 m, perform hand hygiene | |
| Laboratory | Lab technician | Manipulation of respiratory samples. Specimen handling for molecular testing would require BSL-2 or equivalent facilities. Handling and processing of specimens from cases with suspected or confirmed COVID-19 infection that are intended for additional laboratory tests, such as hematology or blood gas analysis, should apply standard precaution | Medical mask, eye protection, gown, gloves | Maintain physical distance of at least 1 m, perform hand hygiene |
Disinfection method of instruments
| Instruments used for procedures | Disinfection method |
|---|---|
| Comedone extractors, electrosurgery tips, microdermabrasion (MDA) tips, cryosurgery equipment, microdermabrasion tips, dermabrasion brushes, hair transplant instruments | Isopropyl alcohol, glutaraldehyde, Ethylene oxide (ETO) |
| Chemical peels, sterile cotton balls, container, brushes (should be avoided) | UV disinfection, ETO, UV sterilization |
| Microdermabrader body | Hypochlorite mist spray between cases |
| LED devices | Face piece for contact with isopropyl alcohol |
| Dermapen and cartridges, microneedles | Isopropyl alcohol between sessions, ETO, glutaraldehyde |
| Mirrors | Isopropyl alcohol |
| Botulinum toxin and fillers | Materials are often prefilled sterile syringes; cannulas and needles are disposable |
| Cooling methods—gel pads | Cleaned with isopropyl alcohol/ice cubes in sterile gloves, avoid direct cooling with gel pads if possible |
| Platelet-rich plasma (PRP) blood collection, injection syringes, and needles | Better to use presterilized disposable material and avoid indigenous methods |
| Thread lifts and suture suspension | Are often presterilized and prepackaged material |
| Autologous micrografts for hair regeneration or skin rejuvenation | Trays should be autoclaved, punches and cups are already presterilized and prepacked |
| Phototherapy chambers | Spray with isopropyl alcohol |
Diagnostic test sensitivity in the days after symptom onset[33]
| DAYS AFTER SYMPTOM ONSET | |||
|---|---|---|---|
| SARS-CoV 2 test | 1-7 | 7-14 | 15-39 |
| RNA by RT PCR | 67% | 54% | 45% |
| Total antibody | 38% | 90% | 100% |
| Ig M | 29% | 73% | 94% |
| Ig G | 19% | 54% | 80% |
Risk stratification of dermatosurgical procedures
| Acne surgery | Subcision | Moderate risk |
| Punch grafting | ||
| Punch elevation | ||
| Nail surgery | Low risk | |
| Vitiligo surgery | Punch grafting | Low risk |
| Other types of vitiligo surgery including epidermal suspension methods needing dermabrasion of recipient area | HR, avoid surgery on lip, nose, chin | |
| Hair transplantation (HT) | HR, postpone HT to moustache, beard area | |
| Excisions of cysts, lipomas | Face | HR |
| Other body sites | Low risk |
HR = high risk
Aesthetic procedures and risk category
| Procedure | Facial area | Nonfacial area |
|---|---|---|
| Chemical peel | MR | LR |
| Spot peels may be preferred | ||
| Botulinum toxin/filler injections | Mid and lower face—MR | For axillary and palmar hyperhidrosis, neck and hand rejuvenation—LR |
| Forehead—LR | ||
| Thread lifts | MR | LR |
| Microneedling with dermaroller | MR | LR |
| Platelet-rich plasma | MR | MR |
| Microdermabrasion | LR | LR |
| Sclerotherapy | MR | LR |
MR = moderate risk, LR = low risk
Energy-based devices and COVID-19 risk
| Procedure | Technology | Risk on face, neck, and scalp | Risk on other parts | Explanation |
|---|---|---|---|---|
| Ablative and Ablative fractional resurfacing | CO2 laser and Er:YAG laser | HR (aerosol) | HR (aerosol) | Plume and aerosol generated. |
| Distance between operator and patient is less. | ||||
| Raw areas are created on patients. | ||||
| Ablative radiofrequency (RF) | HR (aerosol) | HR (aerosol) | ||
| Nonablative lasers and nonablative fractional lasers | Erbium glass | MR | LR | No or minimal fumes generated |
| Thulium | ||||
| IPL (nonhair removal), excimer | ||||
| Q-switched Nd:YAG except carbon peel. | MR | LR | ||
| Laser toning | ||||
| Tattoo removal | HR | MR | ||
| No wounds and usually less painful procedures | ||||
| Carbon peel | Q-switched Nd:YAG laser | HR | HR | A lot of laser plume are generated |
| Laser hair reduction | 810 diode, long-pulsed Nd:YAG, alexandrite, triple wavelength | HR | HR | Significant laser plume is generated |
| IPL | MR? | |||
| Vascular lasers | Pulse dye laser | HR | HR | Significant laser plume is generated |
| LLLT | LR | |||
| Energy-based devices for skin tightening | Monopolar and bipolar RF, HIFU, fractional RF, shockwaves, etc. | MR | LR | No or minimal laser plumes |
| No raw areas |
HR = high risk, MR = moderate risk, LR = low risk, LLLT = Low level laser therapy, HIFU = High intensity frequency ultrasound, IPL = Intense pulse light
Precautions according to risk category
| Risk category for laser procedure | Precautions for healthcare worker | Precautions for patients |
|---|---|---|
| High risk | Full body cover with surgical gown with head cover and N95 mask and face shield. | 1. Wash the area with soap and water before the procedure |
| Double gloves. | 2. Disinfect with surgical spirit before the procedure, wait for 10 min, clean again with distilled water. | |
| Smoke evacuator with HEPA or ULPA filter where needed. | 3. If area around the nose and mouth is not going to be treated, ask patient to wear a surgical mask and goggle. | |
| 4. As these procedures can create raw areas, the patient is advised to use a full facial mask till complete healing | ||
| 5. Full surgical washed gown | ||
| Moderate risks | Apron and N95 mask and face shield. | 1. Wash the area with soap and water before the procedure |
| Double gloves. Head cover where spillage is expected | 2. Disinfect with surgical spirit before the procedure, wait for 10 min, clean again with distilled water. | |
| Smoke evacuator with HEPA or ULPA filter where needed. | 3. If area around the nose and mouth is not going to be treated, ask patient to wear a surgical mask and goggle. | |
| 4. Ask patient not to touch the treated area. | ||
| 5. Full surgical washed gown | ||
| Low risk | Surgical mask, head cap, gloves. | 1. Wash the area with soap and water before the procedure |
| 2. Disinfect with surgical spirit before the procedure, wait for 10 min, clean again with distilled water. | ||
| Mask for the patient |
Risk categorization of phototherapy
| Type of phototherapy | Risk | Comments |
|---|---|---|
| Phototherapy chamber | Moderate risk | Less ventilated closed space. |
| Hand and foot phototherapy | Low risk | Fomites if generated will be risk for next patients |
| Scalp phototherapy | Low risk | Scalp machine can be held by patient |
| Targeted phototherapy | Low risk on body | |
| Moderate risk on face |